Lorena Musco
Aviano, 33081, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Time-varying hazard rates reveal patterns of progression in HR+/HER2- metastatic breast cancer: Towards risk-adapted monitoring.
Journal: Translational oncology
Published: July 06, 2026
Molecular profiling of head and neck squamous cell carcinomas in North-eastern Italy identifies possible tumour cell vulnerabilities.
Journal: Translational oncology
Published: July 04, 2024
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors.
Journal: The Journal of pathology
Published: May 08, 2024
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.
Journal: Cancer communications (London, England)
Published: December 12, 2022
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.
Journal: EMBO molecular medicine
Published: June 04, 2020
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
Journal: The Journal of pathology
Published: May 22, 2020
Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
Journal: Cancer research
Published: June 13, 2019
Assessment of the functional impact on the pre-mRNA splicing process of 28 nucleotide variants associated with Pompe disease in GAA exon 2 and their recovery using antisense technology.
Journal: Human mutation
Published: January 06, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026